About This Fund
Venture capital investment firm. It provide capital and expertise to support breakthrough therapies and medical products. Its portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. It pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and company. It also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics.
Investment Focus
What They Look For
tech-enabled transformational healthcare companies; strong management teams; geography: MENA (Middle East/North Africa), Southeast Asia; post-seed/early VC with revenues and path to profitability; high growth/impact potential; good governance/ESG focus
Preparing to pitch TVM Capital?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →